Printer Friendly

Higher vitamin D levels associated with improved breast and colorectal cancer survival.

An article published online in the European Journal of Cancer reports the results of two meta-analyses conducted by researchers at the German Cancer Research Center in Heidelberg, which affirm a protective effect for higher levels of vitamin D against the risk of dying from breast cancer as well as colorectal cancer.*

The researchers selected five studies that involved 4,413 breast cancer patients and five studies that included 2,330 colorectal cancer patients. Analysis of the selected studies uncovered a 38% average lower risk of dying from any cause and a 42% lower risk of dying from breast cancer when the highest versus lowest categories of serum 25-hydroxyvitamin D levels were compared. For colorectal cancer, the risk averaged 29% lower for all-cause mortality and 35% lower for disease-specific death among the highest groups.


Editor's Note: Authors Haifa Maalmi and colleagues note, "The rather consistent results found in our meta-analyses suggest vitamin D supplementation might bear a potential to improve prognosis among colorectal and breast cancer patients, a suggestion that should be followed up and tested in randomized controlled trials."

* Eur J Cancer 2014 Feb 27.

COPYRIGHT 2014 LE Publications, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2014 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:IN THE NEWS
Author:Dye, D.
Publication:Life Extension
Article Type:Abstract
Geographic Code:4E
Date:Jul 1, 2014
Previous Article:Intolerable delays!
Next Article:Nutritious meals reduce health care expenditures in chronically ill population.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters